Xcout Intel
Theradaptive, Inc.
Theradaptive, Inc. is a clinical-stage biotechnology company headquartered in Frederick, Maryland, that engineers proteins to bind materials for targeted tissue therapeutics, tissue regeneration, and implantable delivery devices.
Subscribe to see Theradaptive, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Theradaptive, Inc. at a glance
Theradaptive, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $36.2M in July 2026. Xcout tracks 13 named people at Theradaptive, Inc., including David Stewart (Chief Operating Officer).
Theradaptive, Inc. leadership
- David StewartChief Operating Officer
- Frank Vizesi, PhDChief Scientific Officer
- Luis M. Alvarez, PhDFounder
- Edward FixVice President of Manufacturing
- Joe TamayoVice President of Regulatory and Quality
- Jonathan Elsner, PhDVice President, Clinical Operations
7 more named people on record for Theradaptive, Inc., with roles, board committees and tenure — see the full roster →
Theradaptive, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $36.2M | — | |
| Seed | $36.2M | 3 named | |
| Seed | $26M | 5 named | |
| Seed | $6.2M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Theradaptive, Inc. competitors
A few of Theradaptive, Inc.'s closest competitors — see the full list of competitors and alternatives →
Eterna Regeneratives develops regenerative biomaterials and protein-derived scaffolds designed for mineralisation and tissue regeneration. The company's initial applications focus on oral health and enamel repair through professional consumer dental care formats, as well as bone regeneration for orthopaedic and bone grafting uses.
Terrestrial Bio, Inc. develops the Tacterra microarray patch platform to deliver next-generation therapies, such as GLP-1, through the skin using dissolvable biomaterial tips. The technology eliminates the need for needles and refrigeration, enabling patients to self-administer treatments pain-free at home or on the go.
Truelastin Laboratories develops natural elastin biomaterials and product platforms for human health applications. The company serves the medical aesthetics and therapeutic sectors by creating tissue-engineered products and advanced drug delivery systems.
OssiFi Inc. is a bone biology company founded in 2014 and located in Overland Park, Kansas. It focuses on developing therapies and medical devices to meet needs in neurogenic conditions.
Precise Bio, Inc. is a clinical-stage regenerative medicine company that grows live organs for transplant using 3D bio-printing technology.
Frontier Bio develops engineered human tissues and vascular grafts to address cardiovascular disease and eliminate the need for organ donors and animal testing. The company provides tissue-engineered blood vessels for vascular grafts and commercializes human-based tissue models and services for preclinical testing.
Get Theradaptive, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Theradaptive, Inc. in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access